Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 523,577 | 136,094 | 201,144 | 169,498 | 206,913 |
| Marketable Securities | 185,072 | 227,447 | 206,018 | 58,088 | 42,491 |
| Receivables | 60,383 | 77,104 | 46,350 | 67,907 | 42,197 |
| Inventories | 17,107 | 16,897 | 16,219 | 16,117 | 13,660 |
| TOTAL | $806,862 | $474,966 | $479,079 | $320,857 | $313,281 |
| Non-Current Assets | |||||
| PPE Net | 18,484 | 15,391 | 14,540 | 12,694 | 8,805 |
| Intangibles | 785,251 | 785,070 | 777,296 | 783,372 | 704,921 |
| Other Non-Current Assets | 30,889 | 16,145 | 12,996 | 2,299 | 1,620 |
| TOTAL | $834,624 | $816,606 | $804,832 | $798,365 | $715,346 |
| Total Assets | $1,641,486 | $1,291,572 | $1,283,911 | $1,119,222 | $1,028,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 20,000 | 16,667 | 11,667 | 6,667 |
| Accounts payable and accrued liabilities | 147,850 | 141,775 | 117,750 | 147,599 | 102,788 |
| Other current liabilities | 6,840 | 4,179 | 3,132 | 3,814 | 3,463 |
| TOTAL | $183,500 | $173,959 | $143,046 | $166,796 | $114,922 |
| Non-Current Liabilities | |||||
| Long Term Debt | 293,149 | 135,683 | 138,468 | 141,347 | 144,258 |
| Deferred Revenues | 8,810 | 8,005 | 5,497 | 3,716 | 2,004 |
| Other Non-Current Liabilities | 354,355 | 27,216 | 339,670 | 310,298 | 218,801 |
| TOTAL | $794,332 | $628,928 | $627,923 | $601,699 | $527,615 |
| Total Liabilities | $977,832 | $802,887 | $770,969 | $768,495 | $642,537 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,631 | 58,950 | 58,431 | 58,402 | 50,455 |
| Common Shares | 61 | 58 | 58 | 51 | 51 |
| Retained earnings | -1,112,822 | -1,052,825 | -1,011,036 | -938,923 | -890,593 |
| Other shareholders' equity | 616 | 1,922 | 805 | 1,462 | 1,628 |
| TOTAL | $663,654 | $488,685 | $512,942 | $350,727 | $386,090 |
| Total Liabilities And Equity | $1,641,486 | $1,291,572 | $1,283,911 | $1,119,222 | $1,028,627 |